Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/pT4 Urothelial Bladder Cancer
Principal Investigator
Libni Eapen, MD FRCPC
Status
Terminated
Date Opened To Accrual
January 02 2015
Date Closed to Accrual
February 01 2017
Date of Study Termination
February 01 2017
Disease Site
Genitourinary [GU]
Bladder
Phase
II
Developmental Therapeutics
No
Primary Objective
To evaluate the ability of post-cystectomy adjuvant radiotherapy to safely reduce pelvic tumor recurrence, defined as pelvic recurrence-free survival.
Patient Population
Patients with pT3/pT4 pN0-2 urothelial (either pure urothelial or primary urothelial mixed with other subtypes) bladder cancer following radical cystectomy.
Target Accrual
185
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.